Prevalence of antibodies against hepatitis A virus among children and adolescents in Germany

Medical Microbiology and Immunology

Volumn 202, Issue 6, 2013, Pages 417-424

  Krumbholz, A ^a,b   Neubert, A ^a   Girschick, H ^c   Huppertz, H I ^d   Kaiser, P ^d   Liese, J ^e   Streng, A ^e   Niehues, T ^f   Peters, J ^g   Sauerbrey, A ^h   Schroten, H ⁱ   Tenenbaum, T ⁱ   Wirth, S ^j   Sauerbrei, A ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b UNIVERSITY OF KIEL   (Germany)

^c Vivantes Clinic in Friedrichshain   (Germany)

^d Children's Hospital   (Germany)

^e UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^f HELIOS Children's Hospital   (Germany)

^g Krankenhaus Dritter Orden   (Germany)

^h HELIOS KLINIKUM ERFURT   (Germany)

ⁱ UNIVERSITY OF HEIDELBERG   (Germany)

^j UNIVERSITY OF WITTEN HERDECKE   (Germany)

more..

Author keywords

Adolescents; Adults; Antibody prevalence; Children; Hepatitis A; Infants

Indexed keywords

HEPATITIS A ANTIBODY;

ADOLESCENT; AGE DISTRIBUTION; ANTIBODY TITER; ARTICLE; CHILD; CONTROLLED STUDY; FEMALE; GERMANY; HEPATITIS A; HEPATITIS A VIRUS; HUMAN; IMMUNIZATION; IMMUNOASSAY; INFANT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEROPREVALENCE; SEX DIFFERENCE;

ADOLESCENT; ADULT; AGE FACTORS; AGED; CHILD; CHILD, PRESCHOOL; FEMALE; GERMANY; HEPATITIS A; HEPATITIS A ANTIBODIES; HUMANS; INFANT; MALE; MIDDLE AGED; SEROEPIDEMIOLOGIC STUDIES; SEX FACTORS; YOUNG ADULT;

EID: 84891371153     PISSN: 03008584     EISSN: 14321831     Source Type: Journal    
DOI: 10.1007/s00430-013-0303-4     Document Type: Article

References (40)

1. Knowles NJ, Hovi T, Hyypiä T, King AMQ, Lindberg AM, Pallansch MA, Palmenberg AC, Simmonds P, Skern T, Stanway G, Yamashita T, Zell R (2012) Picornaviridae. In: King AMQ, Adams MJ, Carstens EB, Lefkowitz EJ (eds) Virus taxonomy: classification and nomenclature of viruses: ninth report of the international committee on taxonomy of viruses. Elsevier, San Diego, pp 855-880
2. Centers for Disease Control and Prevention (1999) Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 48:1-37
3. World Health Organization (2012) Hepatitis A vaccines. Who position paper on hepatitis A vaccines - June 2012. Wkly Epidemiol Rec 87:261-276
4. Heywood AE, Newall AT, Gao Z, Wood JG, Breschkin A, Nicholson S, Gidding HF, Dwyer DE, Gilbert GL, MacIntyre CR (2012) Changes in seroprevalence to hepatitis A in Victoria, Australia: a comparison of three time points. Vaccine 30:6020-6026. doi: 10.1016/j.vaccine.2012.07.058
5. MacKinney-Novelo I, Barahona-Garrido J, Castillo-Albarran F, Santiago-Hernández JJ, Méndez-Sánchez N, Uribe M, Chávez-Tapia N (2012) Clinical course and management of acute hepatitis A infection in adults. Ann Hepatol 11:652-657
6. Nothdurft HD (2008) Hepatitis A vaccines. Expert Rev Vaccines 7:535-537. doi: 10.1586/14760584.7.5.535
7. Jacobsen KH, Koopman JS (2004) Declining hepatitis A seroprevalence: a global review and analysis. Epidemiol Infect 132:1005-1022
8. Kurkela S, Pebody R, Kafatos G, Andrews N, Barbara C, Bruzzone B, Butur D, Caplinskas S, Davidkin I, Hatzakis A, Hellenbrand W, Hesketh LM, Nardone A, Nemecek V, Pistol A, Sobotová Z, Vranckx R, Anastassopoulou CG (2012) Comparative hepatitis A seroepidemiology in 10 European countries. Epidemiol Infect 140:2172-2181. doi: 10.1017/S0950268812000015
9. Weber B, Rabenau H, Berger A, Scheuermann EH, Staszewski S, Kreuz W, Scharrer I, Schoeppe W, Doerr HW (1995) Seroprevalence of HCV, HAV, HBV, HCV, HCMV and HIV in high risk groups/Frankfurt a.M, Germany. Zentralbl Bakteriol 282:102-112
10. Lee HC, Ang LW, Chiew PK, James L, Goh KT (2011) Changing epidemiological patterns of hepatitis A infection in Singapore. Ann Acad Med Singapore 40:439-447
11. Mohd Hanafiah K, Jacobsen KH, Wiersma ST (2011) Challenges to mapping the health risk of hepatitis A virus infection. Int J Health Geograph 10:57
12. Robert Koch-Institut (2013) Aktuelle Statistik meldepflichtiger Infektionskrankheiten, Deutschland. Epidemiol Bull 1:7
13. Robert Koch-Institut (2011) Zu einem Ausbruch durch Hepatitis A in einer Kindertageseinrichtung in Hamburg. Epidemiol Bull 9:65-69
14. Robert Koch-Institut (2011) Hepatitis A-Ausbruch in Rottal Inn. Epidemiol Bull 23:209
15. Anonymous (2013) Häufung von Hepatitis A-Erkrankungen. Vorpommern-Rügen. http://www.lk-vr.de/index.php?object=tx|2151.1. 1&ModID=7&FID=2152.981.1&NavID=2152.10&La=1. Accessed 04 March 2013
16. Lasius D, Lange W, Stück B (1983) Seroepidemiologic studies on hepatitis A infections in German and foreign children living in Berlin (West). Monatsschr Kinderheilkd 131:93-95
17. Bienzle U, Bock HL, Meister W, Clemens R, Kruppenbacher JP (1993) Anti-HAV seroprevalence in German travellers and hepatitis A vaccination in immune subjects. Lancet 341:1028
18. Müller R, Willers H, Frösner GG, Gerlich W, Knocke KW, Sipos S, Deicher H, Höpke W (1978) The seroepidemiological pattern of acute viral hepatitis. An epidemiological study on viral hepatitis in the Hannover region. Infection 6:65-70
19. von Kries V, Weiss S, Falkenhorst G, Wirth S, Kaiser P, Huppertz HI, Tenenbaum T, Schroten H, Streng A, Liese J, Shai S, Niehues T, Girschick H, Kuscher E, Sauerbrey A, Peters J, Wirsing von König CH, Rückinger S, Hampl W, Micher D, Mertens T (2011) Post-pandemic seroprevalence of pandemic influenza A (H1N1) 2009 infection (swine flue) among children < 18 years in Germany. PLoS ONE 6:e23955. doi: 10.1371/journal.pone.0023955
20. Sauerbrei A, Schmitt S, Scheper T, Brandstädt A, Saschenbrecker S, Motz M, Soutschek E, Wutzler P (2011) Seroprevalence of herpes simplex virus type 1 and type 2 in Thuringia, Germany, 1999 to 2006. Eurosurveillance 16(44):pii:20005
21. Robert Koch-Institut (2012) Empfehlungen der Ständigen Impfkommission (STIKO) am Robert Koch-Institut (Stand: Juli 2012). Epidemiol Bull 30:283-310
22. Zentrale Ethikkommission bei der Bundesärztekammer (2003) Die (Weiter-) Verwendung von menschlichen Körpermaterialien für Zwecke der medizinischen Forschung. Zentrale Ethikkommission bei der Bundesä rztekammer, Berlin. http://www.zentrale-ethikkommission.de/page.asp?his=0.1.21. Accessed 16 Jan 2013
23. Anastassopoulou CG, Kafatos G, Nordone A, Andrews N, Pepody RG, Mossong J, Davidkin I, Gelb D, De Ory F, Thierfelder W, Nemecek V, Bruzzone B, Butur D, Barbara C, Sobotová Z, Jones L, Griskevicius A, Hesketh LM, Cohen D, Vrackx R, Tsakris A, Miller E, Hatzakis A (2009) The European Sero-Epidemiology Network 2 (ESEN2): standardization of assay results for hepatitis A virus (HAV) to enable comparisons of seroprevalence data across 15 countries. Epidemiol Infect 137:485-494. doi: 10.1017/S0950268808001155
24. Alatoom A, Ansari MQ, Cuthbert J (2013) Multiple factors contribute to positive results for hepatitis A virus immunoglobulin M antibody. Arch Pathol Lab Med 137:90-95. doi: 10.5858/arpa.2011-0693-OA
25. Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22:719-748
26. Statistisches Bundesamt (2013) Ausländische Bevölkerung am 31.12.2011. Statistisches Bundesamt, Wiesbaden. https://www.destatis.de/DE/ ZahlenFakten /GesellschaftStaat/Bevoelkerung/MigrationIntegration/ AuslaendischeBevolkerung/Tabellen/Bundeslaender.html. Accessed 29 May 2013
27. Jacobsen KH, Koopman JS (2005) The effects of socioeconomic development on worldwide hepatitis A virus seroprevalence patterns. Int J Epidemiol 34:600-609
28. Robert Koch-Institut (2012) Infektionsepidemiologisches Jahrbuch meldepflichtiger Krankheiten für 2011. Robert Koch-Institut, Berlin
29. Faillon S, Martinot A, Hau I, Puget A, Moulin F, Noel G, Gras-Le Guen C, Lorrot M, Callamand P, Hue V, Meritet JF, Gendrel D, Dubos F (2013) Impact of travel on the seroprevalence of hepatitis A in children. J Clin Virol 56:46-51. doi: 10.1016/j.jcv.2012.10.004
30. Mossong J, Putz L, Patiny S, Schneider F (2006) Seroepidemiology of hepatitis A and hepatitis B virus in Luxembourg. Epidemiol Infect 134:808-813
31. Pham B, Duvall B, De Serres G, Gilca V, Tricco AC, Ochnio J, Scheifele DW (2005) Seroprevalence of hepatitis A infection in a low endemicity country: a systemic review. BMC Infect Dis 5:56
32. Sato H, Albrecht P, Reynolds DW, Stagno S, Ennis FA (1979) Transfer of measles, mumps, and rubella antibodies from mother to infant. Am J Dis Child 133:1240-1243
33. Asano Y, Hiroishi Y, Itakura N, Hirose S, Kajita Y, Suga S, Yazaki T (1988) Placental transfer of IgG subclass-specific antibodies to varicella-zoster virus. J Med Virol 26:1-6
34. Wilczynski J, Lukasik B (1994) Transplacental transfer of antibodies to some respiratory viruses. Acta Microbiol Pol 43:347-358
35. Malek A, Sager R, Schneider H (1998) Transport of proteins across the human placenta. Am J Reprod Immunol 40:347-351
36. Sauerbrei A, Groh A, Bischoff A, Prager J, Wutzler P (2002) Antibodies against vaccine-preventable diseases in pregnant women and their offspring in Eastern part of Germany. Med Microbiol Immunol 190:167-172
37. Sauerbrei A, Wutzler P (2002) Placental boost to varicella-zoster antibodies in the newborn. J Perinat Med 30:345-348
38. Wutzler P, Schmidt-Ott R, Hoyer H, Sauerbrei A (2009) Seroprevalence of influenza A and B in pregnant women and their offspring. J Clin Virol 46:161-164. doi: 10.1016/j.jcv.2009.06.024
39. Thierfelder W, Hellenbrand W, Meisel H, Schreier E, Dortschy R (2001) Prevalence of markers for hepatitis A, B and C in the German population. Results of the German National Health Interview and Examination Survey 1998. Eur J Epidemiol 17:429-435
40. Faber MS, Stark K, Behnke SC, Schreier E, Frank C (2009) Epidemiology of hepatitis A virus infections, Germany, 2007-2008. Emerg Infect Dis 15:1760-1768. doi: 10.3201/eid1511.090214